Exploring the entry of traditional Chinese medicine into Medicare, Dr. Chen Jianchao and Mr. Huang Shuliang had a deep exchange!

Recently, Dr. Chen Jianchao, President of the Australian Chinese Medicine Association, had a profound and meaningful exchange with Mr. Huang Shuliang, a Canberra overseas Chinese leader. Zheng Maoqiang, Honorary President of the Australian Chinese Medicine Association, also participated in the dialogue, providing diverse perspectives and strong support. This exchange not only brings new thinking directions for the development of traditional Chinese medicine in Australia, but also gathers forces from both inside and outside the industry to jointly provide strategies for the future of traditional Chinese medicine.

In his illustrious career, Mr. Huang Shuliang has held numerous important positions. He once served as the Chief Pharmacist of the Australian Capital Territory government, ensuring the safety of local residents' medication through professional knowledge in drug management and dispensing; During my tenure as the Chief Pharmacist of the Drug Management Division of the Australian Federal Government's Department of Health, I participated in the development of drug management policies and controlled drug quality and safety checkpoints; As a multicultural ambassador appointed by the former federal government prime minister and an honorary ambassador appointed by the former capital Canberra government, he actively promotes exchanges and integration between different cultures, and builds bridges for multicultural communication; In addition, he is also the founding chairman of the Canberra Multicultural Forum, honorary president (sponsor) of the Australian Chinese Association in the capital, and a 47 year member of the Lions Club International, shining in various fields and contributing to community development and multicultural construction. It is worth mentioning that in 1997, Mr. Huang Shuliang, on behalf of the federal government, signed an agreement with the State Administration of Traditional Chinese Medicine of China on the research of traditional Chinese medicine. The signing of this agreement was a milestone in the development of traditional Chinese medicine in Australia, which greatly promoted the legal registration of traditional Chinese medicine practitioners in Australia, standardized the approval and review procedures for traditional Chinese medicine, and laid a solid foundation for the legalization and standardized development of traditional Chinese medicine in Australia.

During the exchange, Dr. Chen Jianchao and Mr. Huang Shuliang conducted in-depth discussions on the Australian traditional Chinese medicine industry, with the core topic being how Australian traditional Chinese medicine can enter the Medicare system. Dr. Chen Jianchao pointed out that although traditional Chinese medicine has made certain progress in Australia and some private supplementary medical insurance can reimburse the cost of traditional Chinese medicine treatment, it is still difficult to fully include it in the Australian National Medical Insurance (Medicare).

During the exchange, Dr. Chen Jianchao and Mr. Huang Shuliang conducted in-depth discussions on the Australian traditional Chinese medicine industry, with the core topic being how Australian traditional Chinese medicine can enter the Medicare system. Dr. Chen Jianchao pointed out that although traditional Chinese medicine has made certain progress in Australia and some private supplementary medical insurance can reimburse the cost of traditional Chinese medicine treatment, it is still difficult to fully include it in the Australian National Medical Insurance (Medicare). Mr. Huang Shuliang, with his rich experience and profound insights, has expressed unique insights on this topic. He believes that in order for traditional Chinese medicine to successfully enter the Medicare system, strengthening professional norms and standardization construction is the key. In pharmaceutical management, it is necessary to clarify the composition and dosage standards of traditional Chinese medicine to ensure the stability and safety of drug quality; In terms of diagnosis and treatment standards, the diagnostic process and treatment plan of traditional Chinese medicine should be unified to make the treatment process more scientific and reproducible, so that the mainstream society in Australia can see the scientific and rigorous side of traditional Chinese medicine, thereby increasing the possibility of being accepted by the Medicare system.

At the same time, all parties emphasized the importance of strengthening the promotion and education of traditional Chinese medicine. Currently, many Australian people have limited understanding of traditional Chinese medicine, and there are even misunderstandings and biases. Community lectures on traditional Chinese medicine can be held, inviting TCM practitioners to explain TCM theories and showcase TCM treatment methods on site; By utilizing media platforms, producing popular Chinese medicine videos, articles, and other means, we aim to popularize Chinese medicine knowledge to the Australian public, showcase the significant therapeutic effects and unique advantages of Chinese medicine in treating chronic diseases and regulating bodily functions, change people's perception of Chinese medicine, and create a favorable social public opinion environment for the entry of Chinese medicine into the Medicare system.

Dr. Chen Jianchao added that since its establishment, the Australian Traditional Chinese Medicine Chamber of Commerce has been committed to promoting the development of traditional Chinese medicine in Australia, and will also make helping traditional Chinese medicine enter the Medicare system one of its important work goals in the future. The Chamber of Commerce will unite industry forces, integrate resources from all parties, actively communicate and negotiate with government departments, and strive for policy support. At the same time, we will strengthen cooperation with research institutions and universities, conduct research related to traditional Chinese medicine, and provide stronger theoretical and practical basis for the entry of traditional Chinese medicine into the Medicare system.

This exchange provides new ideas and directions for the development of the Australian traditional Chinese medicine industry. I believe that with the joint efforts of knowledgeable individuals like Dr. Chen Jianchao, Mr. Huang Shuliang, and Mr. Zheng Maoqiang, the goal of Australian traditional Chinese medicine entering the Medicare system will gradually be achieved, and traditional Chinese medicine will also play a greater role on this land of Australia, making more contributions to the health and well-being of local people.